Series B - Confo Therapeutics
Investment Firm
Overview
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.
Announced Date
Jul 26, 2024
Funding Type
Series B
Highlights
Location
Europe
Social
Participant Investors
12
Round Details and Background
Confo Therapeutics raised $65148419 on 2024-07-26 in Series B
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.
Company Funding History
11
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 28, 2024 |  Grant - Confo Therapeutics | 1 | - | 1.7M |
| Jul 26, 2024 | Series B - Confo Therapeutics | 13 | - | 65.1M |
| Feb 03, 2017 | Grant - Confo Therapeutics | 1 | - | 1.7M |
| Jun 26, 2015 | Venture Round - Confo Therapeutics | 1 | - | 3.4M |
Recent Activity
There is no recent news or activity for this profile.